We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-8.32%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.29B
AUM Growth
-$303M
Cap. Flow
+$76.4M
Cap. Flow %
2.32%
Top 10 Hldgs %
14.37%
Holding
1,576
New
105
Increased
568
Reduced
547
Closed
231

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.9M
2
KMX icon
CarMax
KMX
+$10.9M
3
NFLX icon
Netflix
NFLX
+$7.39M
4
UAL icon
United Airlines
UAL
+$6.3M
5
AMZN icon
Amazon
AMZN
+$5.34M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$6.94M
2
QCOM icon
Qualcomm
QCOM
+$6.76M
3
BHC icon
Bausch Health
BHC
+$5.37M
4
KMI icon
Kinder Morgan
KMI
+$5.15M
5
PLL
PALL CORP
PLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Healthcare 15.4%
2 Financials 10.61%
3 Consumer Discretionary 9.72%
4 Industrials 9.63%
5 Technology 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HL icon
1251
Hecla Mining
HL
$9.47B
$116K ﹤0.01%
59,039
+24
+0% +$51
IRIX icon
1252
IRIDEX
IRIX
$14.3M
$114K ﹤0.01%
15,000
AWF
1253
AllianceBernstein Global High Income Fund
AWF
$870M
$113K ﹤0.01%
10,197
-1,238
-11% -$14.3K
GGN
1254
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$766M
$111K ﹤0.01%
22,168
+7,400
+50% +$40.4K
MT icon
1255
ArcelorMittal
MT
$52.9B
$111K ﹤0.01%
9,404
-6,516
-41% -$121K
NHS
1256
Neuberger High Yield Strategies Fund Inc
NHS
$251M
$109K ﹤0.01%
10,661
PBR icon
1257
Petrobras
PBR
$125B
$109K ﹤0.01%
24,948
-3,186
-11% -$19.4K
TNXP icon
1258
Tonix Pharmaceuticals
TNXP
$160M
0
STEW
1259
SRH Total Return Fund
STEW
$1.79B
$107K ﹤0.01%
14,329
PRCP
1260
DELISTED
Perceptron Inc
PRCP
$104K ﹤0.01%
13,700
-1,500
-10% -$14.7K
S
1261
DELISTED
Sprint Corporation
S
$104K ﹤0.01%
27,300
-29,765
-52% -$125K
AVP
1262
DELISTED
Avon Products, Inc.
AVP
$104K ﹤0.01%
32,007
+8,838
+38% +$44.8K
XNET
1263
Xunlei
XNET
$340M
$102K ﹤0.01%
14,000
SCU
1264
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$100K ﹤0.01%
1,150
-110
-9% -$11.8K
XONE
1265
DELISTED
The ExOne Company
XONE
$100K ﹤0.01%
14,800
+1,300
+10% +$10.8K
FCH
1266
DELISTED
Felcor Lodging Trust
FCH
$99K ﹤0.01%
14,000
-6,000
-30% -$53.2K
ACCO icon
1267
Acco Brands
ACCO
$389M
$97K ﹤0.01%
13,754
+259
+2% +$1.94K
MCN
1268
Madison Covered Call & Equity Strategy Fund
MCN
$118M
$97K ﹤0.01%
13,700
+1,400
+11% +$10.7K
GLOG
1269
DELISTED
GASLOG LTD
GLOG
$97K ﹤0.01%
10,125
-44,958
-82% -$648K
SZMK
1270
DELISTED
SIZMEK INC COM STK (DE)
SZMK
$96K ﹤0.01%
16,000
-1,250
-7% -$8.47K
EMD
1271
DELISTED
Western Asset Emerging Markets
EMD
$95K ﹤0.01%
10,000
PHYS icon
1272
Sprott Physical Gold
PHYS
$14.6B
$92K ﹤0.01%
10,000
-4,500
-31% -$41.7K
OPCH icon
1273
Option Care Health
OPCH
$3.45B
$86K ﹤0.01%
11,500
-77,000
-87% -$778K
AACG
1274
ATA Creativity
AACG
$39.3M
$84K ﹤0.01%
33,328
ENOC
1275
DELISTED
EnerNOC, Inc.
ENOC
$84K ﹤0.01%
10,590

Similar funds

Oppenheimer & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Oppenheimer & Co held 1,576 positions worth $3.29B, down 8.4% from $3.59B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2015 filing shows 105 new, 568 increased, 547 reduced and 231 closed positions. Its largest new stake was PayPal: 112,571 shares worth $3.49M. The largest sale was ConocoPhillips, an estimated $6.94M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Oppenheimer & Co's largest Q3 2015 buy was PayPal: 112,571 shares worth $3.49M.
  • Oppenheimer & Co added most to Gilead Sciences in Q3 2015, an estimated $15.9M increase.
  • Oppenheimer & Co's biggest Q3 2015 reduction was ConocoPhillips, cutting an estimated $6.94M.
  • Oppenheimer & Co fully exited PALL CORP in Q3 2015, selling an estimated $5.04M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.29B portfolio in Q3 2015.
  • Oppenheimer & Co opened 105 new positions and closed 231 in Q3 2015.
  • Oppenheimer & Co's portfolio value fell 8.4% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q3 2015, filed 13 Nov 2015.